IL1B and brain ischemia: For instance, up-regulation of IL-1R2 in microglial cells and brain endothelial cells attenuated central nervous system (CNS) inflammation in experimental models of IL-1β-induced-neurotoxicity (e.g. central administration of IL-1β, kainic acid administration, cerebral ischemia) (39–41).